These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4334084)

  • 21. Current trends and prospects in surgical adjuvant trials.
    Rozencweig M; von Hoff DD; Louie AC; Muggia FM
    Arch Geschwulstforsch; 1978; 48(7):673-9. PubMed ID: 282827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant chemotherapy for common solid tumors.
    Berstock DA; Baum M
    Adv Cancer Res; 1983; 39():315-27. PubMed ID: 6353886
    [No Abstract]   [Full Text] [Related]  

  • 23. Remission induction in childhood leukemia with second course vincristine (NSC-67574) and prednisone (NSC-10023) therapy.
    Cancer Chemother Rep; 1970 Apr; 54(2):113-8. PubMed ID: 4946001
    [No Abstract]   [Full Text] [Related]  

  • 24. [New perspectives for an adjuvant chemotherapy in solid tumors].
    Schmidt CG; Seeber S
    Dtsch Med Wochenschr; 1975 Nov; 100(45):2342-8. PubMed ID: 171129
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical and biochemical studies of high-dose intermittent therapy of solid tumors with hydroxyurea (NSC-32065).
    Creasey WA; Capizzi RL; DeConti RC
    Cancer Chemother Rep; 1970 Jun; 54(3):191-4. PubMed ID: 4946005
    [No Abstract]   [Full Text] [Related]  

  • 26. Augmentation of the human immune response by cyclophosphamide.
    Berd D; Mastrangelo MJ; Engstrom PF; Paul A; Maguire H
    Cancer Res; 1982 Nov; 42(11):4862-6. PubMed ID: 7127320
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of the toxicity of precautional chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in carcinoma of the breast in the first 700 treatment cycles].
    Sismondi P; Zola P; Galletto L; De Giovanni D; Giardina G
    Minerva Ginecol; 1979; 31(7-8):563-8. PubMed ID: 481814
    [No Abstract]   [Full Text] [Related]  

  • 28. Five-drug combination chemotherapy for disseminated adenocarcinoma.
    Lokich JJ; Skarin AT
    Cancer Chemother Rep; 1972 Dec; 56(6):761-7. PubMed ID: 4660632
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase I study of phenesterin (NSC-104469).
    Ansfield FJ; Carter AC; Goldenberg IS; Segaloff A
    Cancer Chemother Rep; 1971 Jun; 55(3):259-63. PubMed ID: 5000532
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT; Palshof T
    Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of adenocarcinoma with combinations of cyclopjosphamide (NSC-26271), vincristine (NSC-67574), and 5-fluorouracil (NSC-19893).
    Tucker WG; Talley RW; Lane M; Bonnet JD
    Cancer Chemother Rep; 1975; 59(2 Pt 1):425-7. PubMed ID: 1097101
    [No Abstract]   [Full Text] [Related]  

  • 32. Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma.
    Wilcox PM; Fetting JH; Nettesheim KM; Abeloff MD
    Cancer Treat Rep; 1982 Aug; 66(8):1601-4. PubMed ID: 7049385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Children treated with metronomic chemotherapy in a low-income country: METRO-MALI-01.
    Fousseyni T; Diawara M; Pasquier E; André N
    J Pediatr Hematol Oncol; 2011 Jan; 33(1):31-4. PubMed ID: 21164360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination cancer chemotherapy--a clinical trial on outpatients.
    Ti TK; Yong NK
    Med J Malaysia; 1974 Mar; 28(3):165-70. PubMed ID: 4278036
    [No Abstract]   [Full Text] [Related]  

  • 35. [A randomized trial of adriamycin, cyclophosphamide, ftorafur (ACF) and adriamycin, cyclophosphamide, ftorafur, methotrexate (ACFM) in patients with advanced breast cancer].
    Inoue K; Ogawa M; Inagaki J; Horikoshi N; Ikeda K; Nakada H; Usui N; Adachi K; Tada A; Yamazaki H
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1832-7. PubMed ID: 6433805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combined cytostatic treatment of solid tumours with cyclophosphamide (Endoxan), vincristine, methylaminopterin (Methotrexate) and 5-fluorouracil].
    Brincker H
    Ugeskr Laeger; 1971 May; 133(19):926-9. PubMed ID: 5559763
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of cytostatic therapy with cyclophosphamide alone or in combination with methotrexate on the phytohaemagglutinin lymphocyte culture and on the immunoglobulins.
    Lopes Cardozo E
    Oncology; 1970; 24(4):261-72. PubMed ID: 4193797
    [No Abstract]   [Full Text] [Related]  

  • 38. 6-Mercaptopurine (NSC-755) given intermittently in high doses: phase II study.
    Fink DJ; Foye LV
    Cancer Chemother Rep; 1970 Feb; 54(1):31-4. PubMed ID: 4945996
    [No Abstract]   [Full Text] [Related]  

  • 39. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
    Lee JM; Abeloff MD; Lenhard RE; Baker RR
    Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
    [No Abstract]   [Full Text] [Related]  

  • 40. Phase II trial of oral methotrexate and dipyridamole in colorectal carcinoma.
    Wadler S; Subar M; Green MD; Wiernik PH; Muggia FM
    Cancer Treat Rep; 1987 Sep; 71(9):821-4. PubMed ID: 3621214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.